Plain-English translation of NCT06668961 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new treatment called +, given together with platinum-based chemotherapy (a standard cancer drug), for patients whose head and neck cancer has come back or spread to other parts of the body. The research team wants to see how well this medication works and how safe it is when combined with chemotherapy. This is an early-stage trial with about 60 patients.
Head and neck cancers that return or spread are very difficult to treat, and patients need better options. This medication may work alongside chemotherapy to help fight the cancer more effectively than chemotherapy alone.
You likely qualify if…
You likely don't qualify if…
You would receive the new medication (+) along with platinum-based chemotherapy during your first treatment cycle. If your cancer improves or stays stable, you can continue getting more cycles of treatment. Your doctors will monitor you closely for side effects and how well the treatment is working, and will stop if your cancer gets worse or the side effects become too hard to tolerate. The trial involves multiple clinic visits for blood tests, scans, and check-ups to track your progress.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
China